A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Children's Hospital of Philadelphia
Institut Claudius Regaud
Fundación de investigación HM
Northwestern University
St. Jude Children's Research Hospital
Nationwide Children's Hospital
Johns Hopkins University
Milton S. Hershey Medical Center
Mayo Clinic
Case Comprehensive Cancer Center
Milton S. Hershey Medical Center
Hoosier Cancer Research Network
Weill Medical College of Cornell University
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Shenzhen Geno-Immune Medical Institute
University of Texas Southwestern Medical Center
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Washington University School of Medicine
Stanford University
M.D. Anderson Cancer Center
University of California, San Francisco
University of Florida
Washington University School of Medicine
University of Florida
Baptist Health South Florida
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Essen Biotech
Essen Biotech
Grupo Español de Investigación en Neurooncología
Princess Maxima Center for Pediatric Oncology
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Sun Yat-sen University
University of California, San Francisco
Institute of Cancer Research, United Kingdom
St. Jude Children's Research Hospital
Australian & New Zealand Children's Haematology/Oncology Group
University of Alabama at Birmingham
Institute of Cancer Research, United Kingdom
University of California, San Francisco
Ohio State University Comprehensive Cancer Center
University of Birmingham
Memorial Sloan Kettering Cancer Center
AHS Cancer Control Alberta
Boston Children's Hospital
Hoosier Cancer Research Network